Correction to: The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations

Unfortunately, the online published article has errors in Table  2. The Peginterferon is listed as IM, when it should be SC.
Source: Journal of Neurology - Category: Neurology Source Type: research